Punto Health
Latest round
- Seed
Last raised
- Nov 2025
Total raised
- $3.5M
Investors
- 6
About Punto Health
Founded in 2023 and based in London, UK, Punto Health Ltd. operates as a digital healthcare company. The company was founded by its CEO, Anna Muñoz Farré, and Jack Eckersley. In December 2025, Punto Health Ltd. Punto Health develops AI-driven tools for cognitive care, focusing on dementia. The company’s product line includes PuntoCare, an AI-powered assistant designed for patients and caregivers that provides information, resources, and support for managing the disease at home; and PuntoClinic, a platform for managing and monitoring cognitive health that utilizes digital biomarkers for cognitive assessment and integrates other available tests.
Who invested in Punto Health
6 investors across 1 round
See all investors in Punto Health
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Nov 5, 2025
Amount
$3.5M
Investors
Questions about Punto Health
Who invested in Punto Health?
Punto Health has 6 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Punto Health raised?
Punto Health has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Punto Health last raise money?
Punto Health's most recent round on record is a Seed, in Nov 2025.
What does Punto Health do?
Founded in 2023 and based in London, UK, Punto Health Ltd.
Where is Punto Health headquartered?
Punto Health is headquartered in London, UK.
Which VCs invest in companies like Punto Health?
Among active investors with capital left to deploy, Index Ventures, European Investment Bank, Balderton Capital and Sofinnova Partners back software companies at Punto Health's stage. Their profiles are linked below.
VCs backing software startups at Seed
Raising like Punto Health? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.